Delivery Order SPE2DE24D0013-SPE2D625F1HTA
Award Date 8/19/25
Potential Completion Date 8/26/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 15, 2025, with completion scheduled for August 22, 2025. The delivery order, designated 4569128836 for XPCOV2/FLU/RSV-10 diagnostic solutions, carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. This award represents procurement of molecular diagnostic testing capabilities, specifically for detection of...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded a $17,680 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order, designated XPCOV2/FLU/RSV-10, is set to be completed by September 15, 2025, with performance conducted at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (Sunnyvale, CA) on April 23, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of April 30, 2025, and involves no set-aside provisions. This delivery order represents procurement activity under Cepheid's existing indefinite...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...